GSK3B and breast carcinoma: Publically available algorithms (miRanda, TargetScan) were used to explore the precise mechanism by which miR-1229 activates the Wnt/β-catenin pathway in breast cancer, and showed that GSK-3β, APC, and ICAT might be potential targets of miR-1229 (Figure 4C).